nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzphetamine—CYP3A4—Imiquimod—skin cancer	0.233	0.292	CbGbCtD
Benzphetamine—CYP3A4—Temozolomide—skin cancer	0.233	0.292	CbGbCtD
Benzphetamine—CYP3A4—Vismodegib—skin cancer	0.161	0.202	CbGbCtD
Benzphetamine—CYP3A4—Vemurafenib—skin cancer	0.127	0.16	CbGbCtD
Benzphetamine—CYP3A4—Docetaxel—skin cancer	0.0437	0.0548	CbGbCtD
Benzphetamine—Monobenzone—TYR—skin cancer	0.0227	0.837	CrCbGaD
Benzphetamine—Cardiomyopathy—Imiquimod—skin cancer	0.0158	0.0924	CcSEcCtD
Benzphetamine—Cardiomyopathy—Fluorouracil—skin cancer	0.00873	0.051	CcSEcCtD
Benzphetamine—Digestion impaired—Temozolomide—skin cancer	0.00725	0.0424	CcSEcCtD
Benzphetamine—Dyspepsia—Vismodegib—skin cancer	0.00482	0.0282	CcSEcCtD
Benzphetamine—Decreased appetite—Vismodegib—skin cancer	0.00476	0.0278	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Vismodegib—skin cancer	0.00473	0.0276	CcSEcCtD
Benzphetamine—Diarrhoea—Vismodegib—skin cancer	0.00375	0.0219	CcSEcCtD
Benzphetamine—Nausea—Vismodegib—skin cancer	0.00325	0.019	CcSEcCtD
Benzphetamine—Agitation—Imiquimod—skin cancer	0.00325	0.019	CcSEcCtD
Benzphetamine—Palpitations—Imiquimod—skin cancer	0.00313	0.0183	CcSEcCtD
Benzphetamine—Decreased appetite—Vemurafenib—skin cancer	0.00294	0.0172	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00292	0.0171	CcSEcCtD
Benzphetamine—Tachycardia—Imiquimod—skin cancer	0.00282	0.0165	CcSEcCtD
Benzphetamine—Hyperhidrosis—Imiquimod—skin cancer	0.00279	0.0163	CcSEcCtD
Benzphetamine—Anorexia—Imiquimod—skin cancer	0.00275	0.0161	CcSEcCtD
Benzphetamine—Insomnia—Imiquimod—skin cancer	0.00261	0.0153	CcSEcCtD
Benzphetamine—Dyspepsia—Imiquimod—skin cancer	0.00254	0.0148	CcSEcCtD
Benzphetamine—Decreased appetite—Imiquimod—skin cancer	0.00251	0.0147	CcSEcCtD
Benzphetamine—Hypersensitivity—Vemurafenib—skin cancer	0.00249	0.0146	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Imiquimod—skin cancer	0.00249	0.0146	CcSEcCtD
Benzphetamine—Diarrhoea—Vemurafenib—skin cancer	0.00232	0.0135	CcSEcCtD
Benzphetamine—Urticaria—Imiquimod—skin cancer	0.00229	0.0134	CcSEcCtD
Benzphetamine—Dizziness—Vemurafenib—skin cancer	0.00224	0.0131	CcSEcCtD
Benzphetamine—Hypersensitivity—Imiquimod—skin cancer	0.00213	0.0124	CcSEcCtD
Benzphetamine—Headache—Vemurafenib—skin cancer	0.00212	0.0124	CcSEcCtD
Benzphetamine—Nausea—Vemurafenib—skin cancer	0.00201	0.0117	CcSEcCtD
Benzphetamine—Tremor—Temozolomide—skin cancer	0.00199	0.0116	CcSEcCtD
Benzphetamine—Diarrhoea—Imiquimod—skin cancer	0.00198	0.0115	CcSEcCtD
Benzphetamine—Orphenadrine—SCN10A—skin cancer	0.00197	0.0724	CrCbGaD
Benzphetamine—Anorexia—Bleomycin—skin cancer	0.00195	0.0114	CcSEcCtD
Benzphetamine—Agitation—Temozolomide—skin cancer	0.00195	0.0114	CcSEcCtD
Benzphetamine—Dizziness—Imiquimod—skin cancer	0.00191	0.0112	CcSEcCtD
Benzphetamine—Palpitations—Temozolomide—skin cancer	0.00187	0.0109	CcSEcCtD
Benzphetamine—Anorexia—Dactinomycin—skin cancer	0.00182	0.0107	CcSEcCtD
Benzphetamine—Headache—Imiquimod—skin cancer	0.00181	0.0106	CcSEcCtD
Benzphetamine—Decreased appetite—Bleomycin—skin cancer	0.00178	0.0104	CcSEcCtD
Benzphetamine—Nausea—Imiquimod—skin cancer	0.00171	0.01	CcSEcCtD
Benzphetamine—Hyperhidrosis—Temozolomide—skin cancer	0.00167	0.00977	CcSEcCtD
Benzphetamine—Decreased appetite—Dactinomycin—skin cancer	0.00166	0.00972	CcSEcCtD
Benzphetamine—Anorexia—Temozolomide—skin cancer	0.00165	0.00964	CcSEcCtD
Benzphetamine—Urticaria—Bleomycin—skin cancer	0.00163	0.00952	CcSEcCtD
Benzphetamine—Insomnia—Temozolomide—skin cancer	0.00156	0.00914	CcSEcCtD
Benzphetamine—Tachycardia—Fluorouracil—skin cancer	0.00156	0.00909	CcSEcCtD
Benzphetamine—Dyspepsia—Temozolomide—skin cancer	0.00152	0.0089	CcSEcCtD
Benzphetamine—Anorexia—Fluorouracil—skin cancer	0.00152	0.00888	CcSEcCtD
Benzphetamine—Hypersensitivity—Bleomycin—skin cancer	0.00151	0.00883	CcSEcCtD
Benzphetamine—Decreased appetite—Temozolomide—skin cancer	0.0015	0.00879	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Temozolomide—skin cancer	0.00149	0.00873	CcSEcCtD
Benzphetamine—Oxaprozin—PTGS2—skin cancer	0.00149	0.0549	CrCbGaD
Benzphetamine—Insomnia—Fluorouracil—skin cancer	0.00144	0.00842	CcSEcCtD
Benzphetamine—Hypersensitivity—Dactinomycin—skin cancer	0.00141	0.00823	CcSEcCtD
Benzphetamine—Dyspepsia—Fluorouracil—skin cancer	0.0014	0.0082	CcSEcCtD
Benzphetamine—Decreased appetite—Fluorouracil—skin cancer	0.00139	0.0081	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00138	0.00804	CcSEcCtD
Benzphetamine—Urticaria—Temozolomide—skin cancer	0.00137	0.00803	CcSEcCtD
Benzphetamine—Diarrhoea—Dactinomycin—skin cancer	0.00131	0.00765	CcSEcCtD
Benzphetamine—Hypersensitivity—Temozolomide—skin cancer	0.00127	0.00745	CcSEcCtD
Benzphetamine—Urticaria—Fluorouracil—skin cancer	0.00127	0.0074	CcSEcCtD
Benzphetamine—Palpitations—Docetaxel—skin cancer	0.00125	0.00728	CcSEcCtD
Benzphetamine—Nausea—Bleomycin—skin cancer	0.00122	0.00712	CcSEcCtD
Benzphetamine—Diarrhoea—Temozolomide—skin cancer	0.00118	0.00692	CcSEcCtD
Benzphetamine—Hypersensitivity—Fluorouracil—skin cancer	0.00117	0.00686	CcSEcCtD
Benzphetamine—Dizziness—Temozolomide—skin cancer	0.00114	0.00668	CcSEcCtD
Benzphetamine—Nausea—Dactinomycin—skin cancer	0.00114	0.00664	CcSEcCtD
Benzphetamine—Tachycardia—Docetaxel—skin cancer	0.00112	0.00656	CcSEcCtD
Benzphetamine—Anorexia—Docetaxel—skin cancer	0.0011	0.00641	CcSEcCtD
Benzphetamine—Diarrhoea—Fluorouracil—skin cancer	0.00109	0.00637	CcSEcCtD
Benzphetamine—Headache—Temozolomide—skin cancer	0.00108	0.00633	CcSEcCtD
Benzphetamine—Dizziness—Fluorouracil—skin cancer	0.00105	0.00616	CcSEcCtD
Benzphetamine—Insomnia—Docetaxel—skin cancer	0.00104	0.00608	CcSEcCtD
Benzphetamine—Nausea—Temozolomide—skin cancer	0.00103	0.006	CcSEcCtD
Benzphetamine—Dyspepsia—Docetaxel—skin cancer	0.00101	0.00592	CcSEcCtD
Benzphetamine—Decreased appetite—Docetaxel—skin cancer	0.001	0.00584	CcSEcCtD
Benzphetamine—Headache—Fluorouracil—skin cancer	0.000999	0.00583	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Docetaxel—skin cancer	0.000993	0.0058	CcSEcCtD
Benzphetamine—Phenylbutazone—PTGS2—skin cancer	0.000986	0.0363	CrCbGaD
Benzphetamine—Nausea—Fluorouracil—skin cancer	0.000947	0.00553	CcSEcCtD
Benzphetamine—Hypersensitivity—Docetaxel—skin cancer	0.000848	0.00495	CcSEcCtD
Benzphetamine—Diarrhoea—Docetaxel—skin cancer	0.000787	0.0046	CcSEcCtD
Benzphetamine—Dizziness—Docetaxel—skin cancer	0.000761	0.00445	CcSEcCtD
Benzphetamine—Headache—Docetaxel—skin cancer	0.000721	0.00421	CcSEcCtD
Benzphetamine—Nausea—Docetaxel—skin cancer	0.000683	0.00399	CcSEcCtD
Benzphetamine—SLC6A3—nerve—skin cancer	0.000517	0.131	CbGeAlD
Benzphetamine—SLC6A2—nerve—skin cancer	0.000417	0.106	CbGeAlD
Benzphetamine—POR—nipple—skin cancer	0.000407	0.103	CbGeAlD
Benzphetamine—POR—mammalian vulva—skin cancer	0.000238	0.0603	CbGeAlD
Benzphetamine—SLC18A2—female reproductive system—skin cancer	0.000194	0.0492	CbGeAlD
Benzphetamine—ADRA2A—nipple—skin cancer	0.000167	0.0424	CbGeAlD
Benzphetamine—SLC18A2—head—skin cancer	0.000162	0.0411	CbGeAlD
Benzphetamine—ADRA1A—epithelium—skin cancer	0.000148	0.0376	CbGeAlD
Benzphetamine—SLC6A3—head—skin cancer	0.000123	0.0311	CbGeAlD
Benzphetamine—POR—lymph node—skin cancer	0.000119	0.0302	CbGeAlD
Benzphetamine—ADRA2A—connective tissue—skin cancer	0.000119	0.0301	CbGeAlD
Benzphetamine—SLC6A2—female reproductive system—skin cancer	0.000118	0.03	CbGeAlD
Benzphetamine—ADRA1A—lymphoid tissue—skin cancer	0.000114	0.0289	CbGeAlD
Benzphetamine—SLC18A2—lymph node—skin cancer	0.000113	0.0288	CbGeAlD
Benzphetamine—CYP2B6—skin of body—skin cancer	0.000112	0.0283	CbGeAlD
Benzphetamine—SLC6A2—head—skin cancer	9.89e-05	0.0251	CbGeAlD
Benzphetamine—ADRA2A—mammalian vulva—skin cancer	9.77e-05	0.0248	CbGeAlD
Benzphetamine—ADRA1A—head—skin cancer	9.19e-05	0.0233	CbGeAlD
Benzphetamine—CYP2B6—lymphoid tissue—skin cancer	9.04e-05	0.0229	CbGeAlD
Benzphetamine—CYP2B6—female reproductive system—skin cancer	8.72e-05	0.0221	CbGeAlD
Benzphetamine—ADRA2A—female reproductive system—skin cancer	8.37e-05	0.0212	CbGeAlD
Benzphetamine—CYP2B6—head—skin cancer	7.29e-05	0.0185	CbGeAlD
Benzphetamine—ADRA2A—head—skin cancer	6.99e-05	0.0177	CbGeAlD
Benzphetamine—SLC6A2—lymph node—skin cancer	6.92e-05	0.0176	CbGeAlD
Benzphetamine—CYP3A4—female reproductive system—skin cancer	6.59e-05	0.0167	CbGeAlD
Benzphetamine—ADRA2A—lymph node—skin cancer	4.89e-05	0.0124	CbGeAlD
